{
    "2018-08-06": [
        [
            {
                "time": "2018-01-01",
                "original_text": "Does Bausch Face A Reckoning? 5 Key Issues To Look For In Its Earnings",
                "features": {
                    "keywords": [
                        "Bausch",
                        "reckoning",
                        "earnings"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-07-01",
                "original_text": "Merck’s Animal Health Business Witnessed Solid Growth in 1H 2018",
                "features": {
                    "keywords": [
                        "Merck",
                        "animal health",
                        "solid growth"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-07-31",
                "original_text": "Teva Raises Its 2018 Guidance despite Missing Sales Estimate",
                "features": {
                    "keywords": [
                        "Teva",
                        "guidance",
                        "sales estimate"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-07-25",
                "original_text": "Eli Lilly’s Valuations after Its Q2 2018 Earnings",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "valuations",
                        "Q2 earnings"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}